Literature DB >> 30700417

Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice.

M Neale Weitzmann1,2, Susanne Roser-Page1, Tatyana Vikulina2, Daiana Weiss2, Li Hao2, W Hunter Baldwin3, Kanglun Yu4, Natalia Del Mazo Arbona4, Meghan E McGee-Lawrence4,5, Shannon L Meeks3, Christine L Kempton6.   

Abstract

Hemophilia A (HA), a rare X-linked recessive genetic disorder caused by insufficient blood clotting factor VIII, leaves affected individuals susceptible to spontaneous and traumatic hemorrhage. Although males generally exhibit severe symptoms, due to variable X inactivation, females can also be severely impacted. Osteoporosis is a disease of the skeleton predisposing patients to fragility fracture, a cause of significant morbidity and mortality and a common comorbidity in HA. Because the causes of osteoporosis in HA are unclear and in humans confounded by other traditional risk factors for bone loss, in this study, we phenotyped the skeletons of F8 total knockout (F8 TKO) mice, an animal model of severe HA. We found that trabecular bone accretion in the axial and appendicular skeletons of male F8 TKO mice lagged significantly between 2 and 6 months of age, with more modest cortical bone decline. By contrast, in female mice, diminished bone accretion was mostly limited to the cortical compartment. Interestingly, bone loss was associated with a decline in bone formation in male mice but increased bone resorption in female mice, a possible result of sex steroid insufficiency. In conclusion, our studies reveal a sexual dimorphism in the mechanism driving bone loss in male and female F8 TKO mice, preventing attainment of peak bone mass and strength. If validated in humans, therapies aimed at promoting bone formation in males but suppressing bone resorption in females may be indicated to facilitate attainment of peak mass in children with HA to reduce the risk for fracture later in life.

Entities:  

Mesh:

Year:  2019        PMID: 30700417      PMCID: PMC6373738          DOI: 10.1182/bloodadvances.2018027557

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  24 in total

Review 1.  Pathogenesis of osteoporosis: concepts, conflicts, and prospects.

Authors:  Lawrence G Raisz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model.

Authors:  Susanne Roser-Page; Tatyana Vikulina; Majd Zayzafoon; M Neale Weitzmann
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

3.  Increased fracture rates in people with haemophilia: a 10-year single institution retrospective analysis.

Authors:  Nathan D Gay; Sarah C Lee; Meghan S Liel; Paul Sochacki; Michael Recht; Jason A Taylor
Journal:  Br J Haematol       Date:  2015-02-06       Impact factor: 6.998

4.  Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience.

Authors:  B Alioglu; B Selver; H Ozsoy; G Koca; M Ozdemir; Y Dallar
Journal:  Haemophilia       Date:  2011-06-09       Impact factor: 4.287

5.  Bone density in haemophilia: a single institutional cross-sectional study.

Authors:  C L Kempton; A Antun; D M Antoniucci; W Carpenter; M Ribeiro; S Stein; L Slovensky; L Elon
Journal:  Haemophilia       Date:  2013-08-01       Impact factor: 4.287

6.  Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy.

Authors:  Maria Avgeri; Anna Papadopoulou; Helen Platokouki; Kostas Douros; Spyridon Rammos; Polyxeni Nicolaidou; Sophia Aronis
Journal:  J Pediatr Hematol Oncol       Date:  2008-08       Impact factor: 1.289

7.  The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption.

Authors:  M Recht; M S Liel; R T Turner; R F Klein; J A Taylor
Journal:  Haemophilia       Date:  2013-06-04       Impact factor: 4.287

8.  Risk-adjusted mortality rates of elderly veterans with hip fractures.

Authors:  Elizabeth Bass; Dustin D French; Douglas D Bradham; Laurence Z Rubenstein
Journal:  Ann Epidemiol       Date:  2007-04-08       Impact factor: 3.797

9.  Severe and moderate haemophilia A and B in US females.

Authors:  D M Di Michele; C Gibb; J M Lefkowitz; Q Ni; L M Gerber; A Ganguly
Journal:  Haemophilia       Date:  2014-03       Impact factor: 4.287

Review 10.  Physiological and pathophysiological bone turnover - role of the immune system.

Authors:  M Neale Weitzmann; Ighovwerha Ofotokun
Journal:  Nat Rev Endocrinol       Date:  2016-06-17       Impact factor: 43.330

View more
  7 in total

Review 1.  Factor VIII replacement is still the standard of care in haemophilia A.

Authors:  Louis Aledort; Pier Mannuccio Mannucci; Wolfgang Schramm; Michael Tarantino
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

2.  Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due to Natural Aging in a Mouse Model.

Authors:  M Neale Weitzmann; Daiana Weiss; Tatyana Vikulina; Susanne Roser-Page; Kanglun Yu; Meghan E McGee-Lawrence; Chia Ling Tu; Wenhan Chang; Ighovwerha Ofotokun
Journal:  J Infect Dis       Date:  2022-08-12       Impact factor: 7.759

Review 3.  Low Bone Mineral Density in Hemophiliacs.

Authors:  Jennifer Gebetsberger; Michael Schirmer; Walter J Wurzer; Werner Streif
Journal:  Front Med (Lausanne)       Date:  2022-02-02

4.  Therapeutic Effects of Kefir Peptides on Hemophilia-Induced Osteoporosis in Mice With Deficient Coagulation Factor VIII.

Authors:  Chih-Ching Yen; Yao-Wen Liu; Gary Ro-Lin Chang; Ying-Wei Lan; Yung-Tsung Kao; Shin-Nan Cheng; Wei Chen; Chuan-Mu Chen
Journal:  Front Cell Dev Biol       Date:  2022-02-18

Review 5.  Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines.

Authors:  Madison J Petkovic; Huyen A Tran; Peter R Ebeling; Ayse Zengin
Journal:  Haemophilia       Date:  2022-03-15       Impact factor: 4.263

6.  Potential Biochemical Markers and Radiomorphometric Indices as Predictors of Reduced Bone Mass in Patients with Congenital Hemophilia.

Authors:  Sylwia Czajkowska; Joanna Rupa-Matysek; Ewelina Wojtasińska; Kacper Nijakowski; Lidia Gil; Anna Surdacka; Tomasz Kulczyk
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

7.  Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).

Authors:  Emily A Larson; Hillary J Larson; Jason A Taylor; Robert F Klein
Journal:  Calcif Tissue Int       Date:  2021-06-12       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.